TSRI Scientists Discover Naturally-Occurring Mechanism Involved In Regulation Of Angiogenesis; New Anti-Cancer Therapeutic Agents Are Suggested

La Jolla, CA - February 6, 1998 -- For years scientists have studied angiogenesis, the process whereby new blood vessels are formed from pre-existing ones. Except in a few special circumstances, it does not occur in the normal adult. However, angiogenesis plays a key role in a number of diseases associated with new blood vessel growth such as cancer, diabetic retinopathy, macular degeneration and arthritis. Many scientists have worked to develop methods to promote the selective obliteration of new blood vessel cells that could ultimately lead to regression of the neovascularization associated with these diseases. Now, scientists at The Scripps Research Institute have not only uncovered a mechanism to help explain angiogenesis activity, but have developed a recombinant form of a protein fragment that blocks angiogenesis and tumor growth in an in vivo experimental model. This may provide a potentially novel therapeutic approach for diseases associated with neovascularization.

"Our findings show how an enzyme that promotes angiogenesis can be naturally cleaved to produce a fragment that inhibits this process. We determined that this enzyme fragment likely plays a role in normal blood vessel development. Thus, by taking advantage of this knowledge we have incorporated this into an anti-angiogenesis strategy to block tumor growth," according to one of the paper's authors, David A. Cheresh, Ph.D., Professor, Department of Immunology.

The work, "Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity," by Peter C. Brooks, Steve Silleti, Tami L. von Schalscha, Martin Friedlander, and David A. Cheresh, is published in today's issue of Cell.

To grow and, ultimately, metastasize, malignant tumors must attract a rich blood supply to provide nourishment and remove wastes. In earlier studies, the Cheresh laboratory demonstrated that ang

Contact: Robin B. Goldsmith
(619) 784-8134
Scripps Research Institute

Page: 1 2 3

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:

(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, Inc. ... awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of ... optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to meet ...
(Date:7/18/2020)... ... July 16, 2020 , ... A ... of the Invictus Medical Neoasis™ active noise control device to attenuate typical noises ... the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and other ...
(Date:7/10/2020)... ... 2020 , ... Today CJ BIO announced the first in a series of ... taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a ... July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... N.J (PRWEB) , ... July 29, 2020 , ... ... company, and Catalent, the leading global provider of advanced delivery technologies, development, and ... today announced that they have entered into a strategic partnership whereby Catalent will ...
(Date:7/22/2020)... (PRWEB) , ... July 22, 2020 , ... Join experts ... John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... the regulating body in China for drugs and medical devices. Specifically, for medical devices, ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra ... life sciences and food industries, is pleased to announce that Charles Galea has ... Business Development. , Charles is an accomplished and results-driven sales executive with over ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson ... product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at ...
Breaking Biology Technology:
Cached News: